In a severe colitis rat model, AMSC transplantation improved colitis by inhibiting monocyte/macrophage activity, lowering inflammatory markers (TNF-α, IL-6, and IL-1β), and preventing NF-κB activation [20]. The gene discussed is NFKB1; the disease is colitis.